These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7706786)
1. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. Armstrong GD; Rowe PC; Goodyer P; Orrbine E; Klassen TP; Wells G; MacKenzie A; Lior H; Blanchard C; Auclair F J Infect Dis; 1995 Apr; 171(4):1042-5. PubMed ID: 7706786 [TBL] [Abstract][Full Text] [Related]
2. In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2. Takeda T; Yoshino K; Adachi E; Sato Y; Yamagata K Microbiol Immunol; 1999; 43(4):331-7. PubMed ID: 10385199 [TBL] [Abstract][Full Text] [Related]
3. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. Armstrong GD; Fodor E; Vanmaele R J Infect Dis; 1991 Dec; 164(6):1160-7. PubMed ID: 1659599 [TBL] [Abstract][Full Text] [Related]
4. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli. Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728 [TBL] [Abstract][Full Text] [Related]
5. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives. Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732 [TBL] [Abstract][Full Text] [Related]
6. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome. Arbus GS Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954 [TBL] [Abstract][Full Text] [Related]
7. Verotoxin-binding in human renal sections. Lingwood CA Nephron; 1994; 66(1):21-8. PubMed ID: 8107950 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300 [TBL] [Abstract][Full Text] [Related]
9. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro. Bitzan M; Richardson S; Huang C; Boyd B; Petric M; Karmali MA Infect Immun; 1994 Aug; 62(8):3337-47. PubMed ID: 8039905 [TBL] [Abstract][Full Text] [Related]
10. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome. Trachtman H; Christen E Curr Opin Pediatr; 1999 Apr; 11(2):162-8. PubMed ID: 10202627 [TBL] [Abstract][Full Text] [Related]
12. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology. Lingwood CA Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome. Van de Kar NC; Monnens LA; Van Hinsbergh VW Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811 [TBL] [Abstract][Full Text] [Related]
14. Pheno-genotyping of verotoxin 2 (VT2)-producing Escherichia coli causing haemorrhagic colitis and haemolytic uraemic syndrome by direct analysis of patients' stools. Caprioli A; Luzzi I; Gianviti A; Russmann H; Karch H J Med Microbiol; 1995 Nov; 43(5):348-53. PubMed ID: 7562999 [TBL] [Abstract][Full Text] [Related]
15. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin. Peter MG; Lingwood CA Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185 [TBL] [Abstract][Full Text] [Related]
16. Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. Trachtman H; Cnaan A; Christen E; Gibbs K; Zhao S; Acheson DW; Weiss R; Kaskel FJ; Spitzer A; Hirschman GH; JAMA; 2003 Sep; 290(10):1337-44. PubMed ID: 12966125 [TBL] [Abstract][Full Text] [Related]
17. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as the etiologic agent. I. Bacteriology and pathogenesis]. Tschäpe H; Böhme G Kinderarztl Prax; 1991 Jun; 59(6):161-5. PubMed ID: 1921166 [TBL] [Abstract][Full Text] [Related]
18. Verotoxin receptor glycolipid in human renal tissue. Boyd B; Lingwood C Nephron; 1989; 51(2):207-10. PubMed ID: 2644572 [TBL] [Abstract][Full Text] [Related]
19. A receptor decoy inhibits the enterotoxic effects of Clostridium difficile toxin A in rat ileum. Castagliuolo I; LaMont JT; Qiu B; Nikulasson ST; Pothoulakis C Gastroenterology; 1996 Aug; 111(2):433-8. PubMed ID: 8690209 [TBL] [Abstract][Full Text] [Related]
20. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. Lingwood CA; Law H; Richardson S; Petric M; Brunton JL; De Grandis S; Karmali M J Biol Chem; 1987 Jun; 262(18):8834-9. PubMed ID: 3298243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]